Laurus Labs Limited — Updates, 06-12-2024: Press Release

Laurus Bio Pvt Ltd has secured equity investments amounting to ₹ 120 Cr from Eight Roads Ventures and F-Prime Capital, with Laurus Labs co-investing an additional ₹ 40 Cr. Following this investment, ownership stakes will be distributed as 75% for Laurus Labs, 14% for Eight Roads, and 9% for Laurus Bio's promoters on a fully diluted basis. This infusion will primarily enhance fermentation-based manufacturing capabilities to meet increasing customer demand.

The collaboration is poised to strengthen Laurus Bio's R&D and manufacturing infrastructure, enhancing its position in biomanufacturing across sectors like pharmaceuticals and personal care. The leadership of Laurus Labs and Eight Roads Ventures emphasizes a shared commitment to positioning Laurus Bio as a leader in sustainable manufacturing technologies, presenting a positive outlook for future growth in the biopharmaceutical space. Investors should keep an eye on this unfolding partnership and its potential to drive significant advancements in production capabilities.